Literature DB >> 10894418

Influence of maxillary morphology on nasal airway resistance in Marfan's syndrome.

P A Cistulli1, C E Sullivan.   

Abstract

High nasal airway resistance (NAR) has been reported in Marfan's syndrome, and this appears to contribute to the development of obstructive sleep apnoea in these patients. The cause of high NAR in Marfan's syndrome is unknown, but these patients characteristically have a narrow maxilla, which could have an influence on nasal dimensions. The aim of this study was to define the mechanism(s) mediating high NAR in Marfan's syndrome. Five patients with Marfan's syndrome (mean age 29+/-4 (SEM) years) were compared with an equivalent number of normal control subjects (31+/-1 years). NAR was measured by posterior rhinomanometry, before and after topical decongestant, nasal stenting, or both. Dental impressions were taken to evaluate maxillary arch morphology, allowing measurement of the following lateral distances: inter-canine (ICD), inter-premolar (IPD), and inter-molar (IMD). NAR (at a flow of 500 ccm/s) was considerably higher in patients compared with controls at baseline (0.93+/-0.08 vs 0.35+/-0.08 Pa/ccm/s, p < 0.001), and following decongestant and/or stenting. The maxillary arch was considerably narrower in patients. There were strong inverse correlations between the lateral maxillary dimensions and NAR after nasal decongestant, with or without stenting. These results indicate a strong association between maxillary width and NAR, and suggest that maxillary constriction is the dominant mechanism for the high NAR in Marfan's syndrome. The therapeutic implications of this finding warrant further investigation.

Entities:  

Mesh:

Year:  2000        PMID: 10894418     DOI: 10.1080/000164800750000658

Source DB:  PubMed          Journal:  Acta Otolaryngol        ISSN: 0001-6489            Impact factor:   1.494


  10 in total

Review 1.  Non-cardiac manifestations of Marfan syndrome.

Authors:  Anne H Child
Journal:  Ann Cardiothorac Surg       Date:  2017-11

2.  Prevalence of Obstructive Sleep Apnea in Joint Hypermobility Syndrome: A Systematic Review and Meta-Analysis.

Authors:  Karim Sedky; Thomas Gaisl; David S Bennett
Journal:  J Clin Sleep Med       Date:  2019-02-15       Impact factor: 4.062

3.  Marfan syndrome.

Authors:  Eesha Jain; Ramesh Kumar Pandey
Journal:  BMJ Case Rep       Date:  2013-12-11

Review 4.  Effect of Low-Level Laser Therapy on Bone Formation in Rapid Palatal Expansion: A Systematic Review.

Authors:  Arash Farzan; Katayoon Khaleghi; Zeynab Pirayesh
Journal:  J Lasers Med Sci       Date:  2022-03-23

5.  Association between Oro-Facial Defects and Systemic Alterations in Children Affected by Marfan Syndrome.

Authors:  Raffaella Docimo; Paolo Maturo; Francesca D'Auria; Susanna Grego; Micaela Costacurta; Cesare Perugia; Luigi Chiariello
Journal:  J Clin Diagn Res       Date:  2013-04-01

6.  Three-dimensional evaluation of upper airway following rapid maxillary expansion: a CBCT study.

Authors:  Hakan El; Juan Martin Palomo
Journal:  Angle Orthod       Date:  2013-07-18       Impact factor: 2.079

7.  Changes in the upper and lower pharyngeal airway spaces associated with rapid maxillary expansion.

Authors:  Fitin Aloufi; Charles B Preston; Khalid H Zawawi
Journal:  ISRN Dent       Date:  2012-06-18

8.  Dental findings in marfan syndrome: a case report.

Authors:  Busra Bostanci; Emre Korkut; Nımet Unlu
Journal:  J Istanb Univ Fac Dent       Date:  2017-04-03

Review 9.  The Musculoskeletal Manifestations of Marfan Syndrome: Diagnosis, Impact, and Management.

Authors:  Lily Pollock; Ashley Ridout; James Teh; Colin Nnadi; Dionisios Stavroulias; Alex Pitcher; Edward Blair; Paul Wordsworth; Tonia L Vincent
Journal:  Curr Rheumatol Rep       Date:  2021-11-26       Impact factor: 4.592

10.  Obstructive Sleep Apnea, Palatal Morphology, and Aortic Dilatation in Marfan Syndrome Growing Subjects: A Retrospective Study.

Authors:  Giuseppina Laganà; Nicolò Venza; Arianna Malara; Claudio Liguori; Paola Cozza; Calogera Pisano
Journal:  Int J Environ Res Public Health       Date:  2021-03-16       Impact factor: 3.390

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.